| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 70.7MM | +14% |
| Gross Profit | 23.8MM | - |
| Cost Of Revenue | 46.8MM | +16% |
| Operating Income | -57MM | -60% |
| Operating Expenses | 80.8MM | - |
| Net Income | -48.6MM | -64% |
| R&D | 26.3MM | -5% |
| G&A | 24.4MM | -18% |
| Marketing | 21.8MM | +7% |
| Amortization | 8.2MM | -0% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Boston, April 25, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, announced that the company will participate in the Needham Technology, Media and Consumer Conference. Robert Shepardson, Amwell chief financial officer, will participate in a fireside chat on Tuesday, May 14, at a time to be determined, along with one-on-one investor meetings throughout the day. An audio webcast of the fireside chat will be available at investors.amwell.com. About Amwell Amwell i
Boston, April 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, will report its first quarter 2024 operating results Wednesday, May 1. Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The audio webcast can be accessed by visiting the Investors section of the company's website
Key Insights Significantly high institutional ownership implies American Well's stock price is sensitive to their...
The once high-flying telehealth stock has traded below the exchange’s minimum listing requirements for 30 days, according to a new notice.
Amwell’s Class A Common Stock continues to trade on the NYSEBoston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York Stock Exchange (NYSE) informing the company that it is not in compliance with the NYSE’s continued listing minimum price criteria with respect to its Class A common stock because the average closing price of the company’s Class A common stock
Amwell clients to present on automated care, Converge platform integrationBoston, March 06, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, is attending HIMSS 2024, March 11-15, in Orlando, Fla. Company leaders will be in booth #1441 to discuss Amwell’s hybrid care enablement platform, Virtual Nursing solution, automated care and behavioral health programs and how this technology can address workforce shortages, access to care, the mental health crisis and othe
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
In this article, we will be taking a look at the 20 most valuable digital health companies in the US. If you are not interested in reading about the global health market, head straight to the 5 Most Valuable Digital Health Companies In The US. As of the latest data, several digital health companies stand […]
The announcement comes about a week after the telehealth vendor said it had reduced its headcount by about 10% since the end of 2023.
Horner brings to the role 25 years in family medicine, completion of 25,000 virtual care visitsBoston, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, named Cynthia Horner, M.D., FAAFP, as its chief medical officer. Horner has also been named president of Amwell’s clinical partner, Amwell Medical Group (AMG), a nationwide network of clinicians delivering virtual care 24 hours a day, every day, exclusively on the Amwell platform. As chief medical office